HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $363,997 | -6.1% | 353,395 | +5.8% | 0.00% | – |
| Q2 2023 | $387,498 | -23.4% | 334,050 | -0.4% | 0.00% | – |
| Q1 2023 | $506,196 | -42.1% | 335,229 | -4.1% | 0.00% | – |
| Q4 2022 | $873,538 | -40.5% | 349,415 | +0.5% | 0.00% | – |
| Q3 2022 | $1,467,000 | +68.8% | 347,636 | +11.7% | 0.00% | – |
| Q2 2022 | $869,000 | -50.2% | 311,351 | +2.2% | 0.00% | – |
| Q1 2022 | $1,744,000 | -36.1% | 304,733 | +2.0% | 0.00% | – |
| Q4 2021 | $2,729,000 | -23.1% | 298,851 | -9.9% | 0.00% | -100.0% |
| Q3 2021 | $3,547,000 | -23.7% | 331,837 | +10.8% | 0.00% | 0.0% |
| Q2 2021 | $4,649,000 | -15.8% | 299,586 | -12.0% | 0.00% | 0.0% |
| Q1 2021 | $5,519,000 | -26.6% | 340,474 | -4.2% | 0.00% | -50.0% |
| Q4 2020 | $7,522,000 | +41.7% | 355,365 | -0.8% | 0.00% | +100.0% |
| Q3 2020 | $5,307,000 | -2.3% | 358,114 | -3.0% | 0.00% | 0.0% |
| Q2 2020 | $5,430,000 | +30.1% | 369,159 | +3.8% | 0.00% | 0.0% |
| Q1 2020 | $4,174,000 | -51.1% | 355,555 | -2.1% | 0.00% | -50.0% |
| Q4 2019 | $8,539,000 | +38.0% | 363,354 | +8.7% | 0.00% | 0.0% |
| Q3 2019 | $6,186,000 | +7.4% | 334,372 | +7.9% | 0.00% | 0.0% |
| Q2 2019 | $5,758,000 | -20.9% | 309,770 | +4.0% | 0.00% | 0.0% |
| Q1 2019 | $7,277,000 | -5.9% | 297,740 | -0.1% | 0.00% | 0.0% |
| Q4 2018 | $7,732,000 | -22.0% | 298,065 | -4.9% | 0.00% | -33.3% |
| Q3 2018 | $9,916,000 | -14.8% | 313,312 | +4.7% | 0.00% | 0.0% |
| Q2 2018 | $11,632,000 | +50.8% | 299,384 | +7.1% | 0.00% | +50.0% |
| Q1 2018 | $7,712,000 | +112.3% | 279,418 | +39.2% | 0.00% | +100.0% |
| Q4 2017 | $3,633,000 | +10.3% | 200,699 | -1.6% | 0.00% | 0.0% |
| Q3 2017 | $3,295,000 | +16.1% | 203,995 | -0.4% | 0.00% | 0.0% |
| Q2 2017 | $2,837,000 | -0.8% | 204,857 | +7.4% | 0.00% | 0.0% |
| Q1 2017 | $2,861,000 | +45.4% | 190,771 | +27.1% | 0.00% | 0.0% |
| Q4 2016 | $1,967,000 | -23.9% | 150,114 | +0.1% | 0.00% | 0.0% |
| Q3 2016 | $2,584,000 | -3.3% | 149,932 | +1.3% | 0.00% | 0.0% |
| Q2 2016 | $2,672,000 | -1.9% | 147,986 | +3.2% | 0.00% | 0.0% |
| Q1 2016 | $2,723,000 | -30.9% | 143,407 | -2.8% | 0.00% | 0.0% |
| Q4 2015 | $3,938,000 | +34.0% | 147,473 | +22.4% | 0.00% | 0.0% |
| Q3 2015 | $2,939,000 | -18.0% | 120,469 | +4.7% | 0.00% | 0.0% |
| Q2 2015 | $3,584,000 | +63.0% | 115,028 | -23.9% | 0.00% | 0.0% |
| Q1 2015 | $2,199,000 | +107.3% | 151,179 | +43.2% | 0.00% | – |
| Q4 2014 | $1,061,000 | +18.4% | 105,561 | -1.9% | 0.00% | – |
| Q3 2014 | $896,000 | -56.8% | 107,591 | -36.2% | 0.00% | – |
| Q2 2014 | $2,076,000 | – | 168,540 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |